Equities

Mono Pharmacare Ltd

MONOPHARMA:NSI

Mono Pharmacare Ltd

Actions
  • Price (INR)34.95
  • Today's Change1.65 / 4.95%
  • Shares traded12.00k
  • 1 Year change+9.39%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 10:16 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2023202320222021
ASSETS
Cash And Short Term Investments7.992.451.73
Total Receivables, Net3899165
Total Inventory3884741
Prepaid expenses------
Other current assets, total8.720.240.54
Total current assets793141108
Property, plant & equipment, net112.973.91
Goodwill, net------
Intangibles, net------
Long term investments5.7300
Note receivable - long term0.15----
Other long term assets0----
Total assets811144112
LIABILITIES
Accounts payable1393313
Accrued expenses------
Notes payable/short-term debt2964951
Current portion long-term debt/capital leases------
Other current liabilities, total263.221.94
Total current liabilities4618665
Total long term debt170159.86
Total debt4666461
Deferred income tax------
Minority interest0.03----
Other liabilities, total0.000.000.00
Total liabilities63110175
SHAREHOLDERS EQUITY
Common stock1674337
Additional paid-in capital------
Retained earnings (accumulated deficit)1300
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1804337
Total liabilities & shareholders' equity811144112
Total common shares outstanding181818
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.